NASDAQ: ATRCAtricure Inc Stock Ownership - Who owns Atricure?
Insider buying vs selling
Have Atricure Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Justin J. Noznesky | Chief Mktg Strategy Officer | 2025-09-12 | 3,000 | $36.30 | $108.90kSell |
| Sven Wehrwein | Director | 2025-08-22 | 5,000 | $19.95 | $99.75kBuy |
| Sven Wehrwein | Director | 2025-08-22 | 5,000 | $37.00 | $185.00kSell |
| Sven Wehrwein | Director | 2025-08-19 | 5,000 | $19.95 | $99.75kBuy |
| Sven Wehrwein | Director | 2025-08-19 | 5,000 | $36.00 | $180.00kSell |
| Regina E. Groves | Director | 2025-08-06 | 2,452 | $36.82 | $90.28kSell |
| Vinayak Doraiswamy | Chief Scientific Officer | 2025-08-05 | 2,500 | $36.58 | $91.45kSell |
| Douglas J. Seith | Chief Operating Officer | 2025-06-30 | 550 | $25.84 | $14.21kBuy |
| Vinayak Doraiswamy | Chief Scientific Officer | 2025-06-30 | 822 | $25.84 | $21.24kBuy |
| Karl S. Dahlquist | Chief Legal Officer | 2025-06-30 | 822 | $25.84 | $21.24kBuy |
ATRC insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ATRC insiders and whales buy or sell their stock.
ATRC Shareholders
What type of owners hold Atricure Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Vanguard Group Inc | 9.87% | 4,906,218 | $182.71M | Institution |
| Discovery Group I LLC | 9.76% | 4,853,117 | $180.73M | Insider |
| Blackrock Inc | 8.09% | 4,022,468 | $149.80M | Institution |
| Wellington Management Group LLP | 7.99% | 3,969,269 | $147.82M | Institution |
| Alliancebernstein LP | 7.19% | 3,573,649 | $133.08M | Institution |
| Hood River Capital Management LLC | 6.16% | 3,061,059 | $113.99M | Institution |
| Macquarie Group Ltd | 5.04% | 2,503,205 | $93.22M | Institution |
| Champlain Investment Partners LLC | 4.06% | 2,016,754 | $75.10M | Institution |
| Richard M. Johnston | 3.81% | 1,892,454 | $70.47M | Insider |
| Michael D. Hooven | 3.73% | 1,855,477 | $69.10M | Insider |
ATRC vs Medical Stocks
Atricure Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.